Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to assess the safety, tolerability and effectiveness of a switching from Domin®
(talipexole) tablet to BI Sifrol® (pramipexole) tablet in patients with Parkinson's disease